Reproductive Health News

Women aged 30 years or younger were more likely to report feelings of surgical and loss-of-fertility regret after undergoing laparoscopic hysterectomy vs. women aged 31 to 49 years, researchers reported in Obstetrics & Gynecology.

Using a levonorgestrel-releasing intrauterine system device to prevent pregnancy increased risk for breast cancer among women living in Denmark aged 15 to 49 years, according to a research letter published in JAMA.

Miscarriage care is often suboptimal for women in Canada experiencing early pregnancy loss and providers should be aware of maternal psychological effects to provide compassionate assessment, management and follow-up, researchers reported.

For pregnant women on bed rest, a foam roller intervention improved lower limb venous blood flow compared with controls, mitigating deep vein thrombosis risk and muscle atrophy, researchers reported.

Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Judy Simon, MS, RDN, CD, CHES, FAND, about how women seeking to conceive, whether naturally or with assisted reproduction, can optimize nutrition to boost fertility.

In the past 2 decades, vitamin A, vitamin C and iron intake decreased among women of reproductive age in the U.S., which may substantially impact maternal and fetal health, according to study findings published in JAMA Network Open.

Infants conceived after assisted reproductive technology had a 36% greater risk for being born with a major heart defect, results from a large cohort study published in the European Heart Journal showed.

Ryan Program directors noted limitations on provided abortion services at training hospitals with differences in services, restrictions and colleague support based on state-restrictive status, according to a survey published in O&G Open.

Screening pregnancies without traditional risk factors for spontaneous preterm birth risk with a biomarker blood test and targeting preventive treatments for high-risk women reduced neonatal hospitalization, morbidity and mortality.

Women with early pregnancy loss who received misoprostol alone without pretreatment with mifepristone were more likely to receive subsequent procedural management and have visits to the ED, researchers reported.